Zobrazeno 1 - 10
of 42
pro vyhledávání: '"MESH: Renal Insufficiency"'
Autor:
Mohammad Radwanur Talukder, Richard Woodman, Hai Pham, Kim Wilson, Antoine Gessain, John Kaldor, Lloyd Einsiedel
Publikováno v:
Clinical Infectious Diseases
Clinical Infectious Diseases, 2023, 76 (3), pp.e820-e826. ⟨10.1093/cid/ciac614⟩
Clinical Infectious Diseases, 2023, 76 (3), pp.e820-e826. ⟨10.1093/cid/ciac614⟩
Background A link between chronic inflammation and several noncommunicable diseases (NCDs) has been established. Although chronic infection with the human T-cell leukemia virus type 1 (HTLV-1) is the recognized cause of several inflammatory diseases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b2eb21bea2273d04470e6fdd25bbef7
https://hal-pasteur.archives-ouvertes.fr/pasteur-04079366
https://hal-pasteur.archives-ouvertes.fr/pasteur-04079366
Autor:
Mark Sulkowski, Laura E. Telep, Massimo Colombo, Francois Durand, K. Rajender Reddy, Eric Lawitz, Marc Bourlière, Nelson Cheinquer, Stacey Scherbakovsky, Liyun Ni, Lindsey Force, Heribert Ramroth, Anuj Gaggar, Anand P. Chokkalingam, Meghan E. Sise
Publikováno v:
Alimentary Pharmacology & Therapeutics (Suppl)
Alimentary Pharmacology & Therapeutics (Suppl), 2022, 55 (9), pp.1169-1178. ⟨10.1111/apt.16830⟩
Alimentary Pharmacology & Therapeutics (Suppl), 2022, 55 (9), pp.1169-1178. ⟨10.1111/apt.16830⟩
Background: Sofosbuvir, a prodrug nucleoside inhibitor of hepatitis C virus, has a predominant circulating metabolite that is renally eliminated. Whether sofosbuvir is associated with chronic kidney disease (CKD) progression is not well understood.Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3f47067c4c65c4697a03002ab8a4405
https://www.hal.inserm.fr/inserm-04050685/document
https://www.hal.inserm.fr/inserm-04050685/document
Publikováno v:
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, 2022, 88 (11), pp.4928-4932. ⟨10.1111/bcp.15482⟩
British Journal of Clinical Pharmacology, 2022, 88 (11), pp.4928-4932. ⟨10.1111/bcp.15482⟩
International audience; Measuring uracil (U) levels in plasma is a convenient surrogate to establish dihydropyrimidine dehydrogenase (DPD) status in patients scheduled with 5-fluorouracil (5-FU) or capecitabine. To what extent renal impairment could
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2446841dd6e4869e82035b78c64bb9f
https://inria.hal.science/hal-03923650
https://inria.hal.science/hal-03923650
Autor:
Paul Beunon, Maxime Barat, Anthony Dohan, Lynda Cheddani, Lisa Males, Pedro Fernandez, Bruno Etain, Frank Bellivier, Emeline Marlinge, François Vrtovsnik, Emmanuelle Vidal‐Petiot, Antoine Khalil, Jean‐Philippe Haymann, Martin Flamant, Nahid Tabibzadeh
Publikováno v:
European Journal of Clinical Investigation
European Journal of Clinical Investigation, 2022, 52 (5), pp.e13756. ⟨10.1111/eci.13756⟩
European Journal of Clinical Investigation, 2022, 52 (5), pp.e13756. ⟨10.1111/eci.13756⟩
International audience; Background: Lithium therapy during bipolar disorder is associated with an increased risk of chronic kidney disease (CKD) that is slowly progressive and undetectable at early stages. We aimed at identifying kidney image texture
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a7cdf7056e36f18e53c3f81e49f34d9
https://pubmed.ncbi.nlm.nih.gov/35104368
https://pubmed.ncbi.nlm.nih.gov/35104368
Publikováno v:
Toxins
Toxins, 2020, 12 (12), pp.811. ⟨10.3390/toxins12120811⟩
Toxins, MDPI, 2020, 12 (12), pp.811. ⟨10.3390/toxins12120811⟩
Toxins, Vol 12, Iss 811, p 811 (2020)
Toxins, 2020, 12 (12), pp.811. ⟨10.3390/toxins12120811⟩
Toxins, MDPI, 2020, 12 (12), pp.811. ⟨10.3390/toxins12120811⟩
Toxins, Vol 12, Iss 811, p 811 (2020)
International audience; Vascular calcification (VC) is a cardiovascular complication associated with a high mortality rate, especially in patients with diabetes, atherosclerosis or chronic kidney disease (CKD). In CKD patients, VC is associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3273b68f8f49c34680551fe19802ec47
http://europepmc.org/articles/PMC7767379
http://europepmc.org/articles/PMC7767379
Autor:
Andrew S. Levey, Armando Teixeira-Pinto, Samuel Fung, Nicole Scholes-Robertson, Gloria Ashuntantang, Laura Cortés Sanabria, Samaya Anumudu, Amelie Bernier-Jean, Martin Howell, Louese Dunn, Tim Usherwood, Eduardo Lorca, Martin Wilkie, Andrea Matus Gonzalez, Magdalena Madero, Ikechi G. Okpechi, Daniel Gallego, Jonathan C. Craig, Adeera Levin, Allison Tong, Patrick Rossignol, Katherine Widders, Yeoungjee Cho, Ian H. de Boer, Andrea K. Viecelli, David C. Wheeler, Nicole Evangelidis, Bénédicte Sautenet, Laura Sola, Chandana Guha
Publikováno v:
Trials
Trials, BioMed Central, 2021, 22 (1), pp.612. ⟨10.1186/s13063-021-05574-1⟩
Trials, 2021, 22 (1), pp.612. ⟨10.1186/s13063-021-05574-1⟩
Trials, Vol 22, Iss 1, Pp 1-8 (2021)
Trials, BioMed Central, 2021, 22 (1), pp.612. ⟨10.1186/s13063-021-05574-1⟩
Trials, 2021, 22 (1), pp.612. ⟨10.1186/s13063-021-05574-1⟩
Trials, Vol 22, Iss 1, Pp 1-8 (2021)
Background Globally, over 1.2 million people die from chronic kidney disease (CKD) every year. Patients with CKD are up to 10 times more likely to die prematurely than progress to kidney failure requiring kidney replacement therapy. The burden of sym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e11904fc9a6bd0955fcfe37102b68c2
https://doi.org/10.1186/s13063-021-05574-1
https://doi.org/10.1186/s13063-021-05574-1
Autor:
Raynaud, Marc, Aubert, Olivier, Divard, Gillian, Reese, Peter P, Kamar, Nassim, Yoo, Daniel, Chin, Chen-Shan, Bailly, Élodie, Buchler, Matthias, Ladrière, Marc, Le Quintrec, Moglie, Delahousse, Michel, Jurić, Ivana, Bašić-Jukić, Nikolina, Crespo, Marta, Silva, Helio Tedesco, Linhares, Kamilla, Ribeiro de Castro, Maria Cristina, Soler Pujol, Gervasio, Empana, Jean-Philippe, Ulloa, Camilo, Akalin, Enver, Böhmig, Georg, Huang, Edmund, Stegall, Mark D, Bentall, Andrew J, Montgomery, Robert A, Jordan, Stanley C, Oberbauer, Rainer, Segev, Dorry L, Friedewald, John J, Jouven, Xavier, Legendre, Christophe, Lefaucheur, Carmen, Loupy, Alexandre
Publikováno v:
The Lancet Digital Health
The Lancet Digital Health, 2021, 3 (12), pp.e795-e805. ⟨10.1016/S2589-7500(21)00209-0⟩
The Lancet: Digital Health, Vol 3, Iss 12, Pp e795-e805 (2021)
The Lancet Digital Health, 2021, 3 (12), pp.e795-e805. ⟨10.1016/S2589-7500(21)00209-0⟩
The Lancet: Digital Health, Vol 3, Iss 12, Pp e795-e805 (2021)
Summary: Background: Kidney allograft failure is a common cause of end-stage renal disease. We aimed to develop a dynamic artificial intelligence approach to enhance risk stratification for kidney transplant recipients by generating continuously refi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1342b3bb572f2e7107a604672e0d3d6f
https://hal.umontpellier.fr/hal-03645221
https://hal.umontpellier.fr/hal-03645221
Publikováno v:
Revue medicale suisse
Revue medicale suisse, 2020, 16 (703), pp.1489-1493
Revue medicale suisse, 2020, 16 (703), pp.1489-1493
In chronic kidney disease (CKD) patients, the dosage of many medications should be adapted according to the glomerular filtration rate (GFR). GFR estimation is obtained by using creatinine-based equations. Many different equations have been proposed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::347a4dd263717c2e3ae4f1fc6606f049
https://hal.umontpellier.fr/hal-03340165
https://hal.umontpellier.fr/hal-03340165
Autor:
Dominick J. Angiolillo, Davide Capodanno, Thomas O. Bergmeijer, Tabassome Simon, Dirk Sibbing, Nicolas Danchin, Jurriën M. ten Berg, Matthew J. Price
Publikováno v:
JACC: Cardiovascular Interventions
JACC: Cardiovascular Interventions, Elsevier/American College of Cardiology, 2020, 13 (5), pp.606-617. ⟨10.1016/j.jcin.2020.01.226⟩
JACC: Cardiovascular Interventions, Elsevier/American College of Cardiology, 2020, 13 (5), pp.606-617. ⟨10.1016/j.jcin.2020.01.226⟩
Objectives The aim of this study was to develop a risk score integrating cytochrome P450 2C19 loss-of-function genotypes with clinical risk factors influencing clopidogrel response that would allow the identification with more precision of subjects a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7c513d6f2e4a3ad860d92da2243e134
https://hal.sorbonne-universite.fr/hal-03030882
https://hal.sorbonne-universite.fr/hal-03030882
Publikováno v:
BMJ Case Reports
BMJ Case Reports, BMJ Publishing Group, 2021, 14 (6), pp.e239411. ⟨10.1136/bcr-2020-239411⟩
BMJ Case Rep
BMJ Case Reports, BMJ Publishing Group, 2021, 14 (6), pp.e239411. ⟨10.1136/bcr-2020-239411⟩
BMJ Case Rep
International audience; We present two French cases of amyloid-associated (AA) amyloidosis secondary to chronic infections. Patient 1, a 51-year-old heroin addict, was hospitalised for chest pain and anasarca. During hospitalisation, a nephrotic synd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af296dca6f6b2f13e5f96f33b28fd8c8
https://doi.org/10.1136/bcr-2020-239411
https://doi.org/10.1136/bcr-2020-239411